[Study of HCV infection and viremia in patients with posttransfusion hepatitis in China]

Z Y Tang1, D L Yang, Z Q Yu

  • 1Abteilung für Klinische Immunologie, Tongji Klinik, Tongji Medizinische Universität, Wuhan.

Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao
|January 1, 1995
PubMed

Insights

Hepatitis C virus (HCV) is the primary cause of posttransfusion hepatitis (PTH). While some patients also show Hepatitis B virus (HBV) markers, further research is needed on HCV and HBV interactions.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Posttransfusion hepatitis (PTH) remains a concern following blood transfusions.
  • Identifying causative agents is crucial for effective prevention and treatment.

Purpose of the Study:

  • To investigate the etiological agents of posttransfusion hepatitis (PTH) in 169 patients.
  • To determine the detection timeframes for Hepatitis C virus (HCV) antibodies and RNA.
  • To analyze the patterns of HCV viremia in a follow-up cohort.

Main Methods:

  • Serological testing and Polymerase Chain Reaction (PCR) were employed.
  • Detection of anti-HCV antibodies and HCV RNA.
  • Follow-up serological and viremia assessments over 1.5 to 3 years.

Main Results:

  • Hepatitis C virus (HCV) was identified as the predominant cause of PTH.
  • Hepatitis B virus (HBV) markers were positive in 24 out of 169 patients.
  • Anti-HCV antibodies appeared within 7 days to 1 year (average 54.62 days); HCV RNA was detected earlier (average 8.72 days).
  • Follow-up revealed transient, persistent, or intermittent HCV viremia in all patients, with sustained anti-HCV positivity.

Conclusions:

  • HCV is the main etiological agent in posttransfusion hepatitis.
  • Early detection of HCV infection is possible through RNA testing.
  • HCV viremia patterns vary, and the interplay with HBV requires further investigation.